Gentamicin pharmacokinetics in 1,640 patients: Method for control of serum concentrations

D. E. Zaske, R. J. Cipolle, John C Rotschafer, L. D. Solem, N. R. Mosier, R. G. Strate

Research output: Contribution to journalArticlepeer-review

119 Scopus citations

Abstract

The pharmacokinetics and dosage requirements of gentamicin were studied in 1,640 patients receiving treatment for gram-negative infections. A wide interpatient variation in the kinetic parameters of the drug occurred in all patients and in patients who had normal serum creatinine or normal creatinine clearance. The half-life ranged from 0.4 to 32.7 h in 1,369 patients who had normal serum creatinine and from 0.4 to 7.6 h in 331 patients who had normal creatinine clearance. The factors related to the elimination rate constant were creatinine clearance, age, distribution volume, weight, gender, and hematocrit. The daily dose necessary to obtain therapeutic serum concentrations ranged from 0.5 to 25.8 mg/kg in patients with normal serum creatinine and from 0.7 to 25.8 mg/kg in patients with normal creatinine clearance. In 13 patients (0.9%), a significant change in base-line serum creatinine (≥0.5 mg/dl) occurred during or after treatment, which may have been gentamicin-associated toxicity. Overt cochlear or vestibular toxicity did not occur in these patients. The method of individualizing dosage regimens provided a clinically useful means of rapidly attaining therapeutic peak and trough serum concentrations.

Original languageEnglish (US)
Pages (from-to)407-411
Number of pages5
JournalUnknown Journal
Volume21
Issue number3
DOIs
StatePublished - Jan 1 1982

Fingerprint

Dive into the research topics of 'Gentamicin pharmacokinetics in 1,640 patients: Method for control of serum concentrations'. Together they form a unique fingerprint.

Cite this